Keywords: medimmune, opens, new, unit, uk, anglo-swedish, drug

MedImmune opens new R&D unit in UK

Article | 27 October 2008

Print This

MedImmune, a unit of Anglo-Swedish drug major AstraZeneca, has opened a new, biologics R&D facility in Cambridge, UK. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in